Skip to main content


Full Schedule

Full Schedule

  • Friday, September 16, 2022
  • 7:15 AM – 7:30 AM CT
    Welcome Kick-off Address
  • 7:30 AM – 8:45 AM CT
    Agitation Associated with Alzheimer’s Dementia (AAD): Clinical Presentation & Pathophysiology, Current Treatment & Unmet Need
  • 7:30 AM – 8:45 AM CT
    Forging a New Path: Targeting Muscarinic Receptor Circuits in Schizophrenia
  • 8:50 AM – 12:30 PM CT
    Geriatric Psychiatry Update Pre-Conference Part 1
  • 8:50 AM – 12:30 PM CT
    Psychopharmacology Essentials; Primer for the 21st Century Clinician Pre-Conference Part 1
  • 12:35 PM – 1:50 PM CT
    A nonstimulant treatment option for ADHD
  • 12:35 PM – 1:50 PM CT
    Evidence-based Treatment Considerations in Treatment-resistant Depression
  • 2:00 PM – 4:30 PM CT
    Geriatric Psychiatry Update Pre-Conference Part 2
  • 2:00 PM – 4:30 PM CT
    Psychopharmacology Essentials; Primer for the 21st Century Clinician Pre-Conference Part 2
  • 4:45 PM – 6:15 PM CT
    Eric C. Arauz Memorial Keynote Address: Me2/ - Classical Music for Mental Health
  • 6:30 PM – 7:45 PM CT
    Strategies to Optimize Patient Outcomes in Bipolar I Disorder
  • Saturday, September 17, 2022
  • 7:15 AM – 8:15 AM CT
    Welcome Session: Healing: Our Path from Mental Illness to Mental Health
  • 8:30 AM – 9:45 AM CT
    Marijuana and Young People: A Combustible Combination
  • 8:30 AM – 9:45 AM CT
    Neurobiology and Pharmacology of Agitation and Irritability: Metadiagnostic Importance.
  • 8:30 AM – 9:45 AM CT
    State of Depression
  • 8:30 AM – 9:45 AM CT
    Telehealth Rules and Regulations: A Post-Pandemic Update
  • 8:30 AM – 9:45 AM CT
    The Muscarinic Cholinergic System's Role in Schizophrenia: Pathophysiology and Emerging Treatments
  • 10:00 AM – 11:15 AM CT
    DSM-5 Text Revision (DSM-5-TR): What’s New and What’s Different
  • 10:00 AM – 11:15 AM CT
    Managing ADHD and Comorbidities
  • 10:00 AM – 11:15 AM CT
    Measurement-Based Care in Depression and Beyond: What is it and how to make it work for your patients?
  • 10:00 AM – 11:15 AM CT
    Prevalence Of Autism Spectrum Disorder And Its Comorbid Conditions
  • 10:00 AM – 11:15 AM CT
    Taking a Team Approach to Parkinson Disease Psychosis: Evolving Strategies for Patients With or Without Dementia
  • 11:30 AM – 12:45 PM CT
    Addressing Persistent Myths and Misconceptions in Tardive Dyskinesia
  • 11:30 AM – 12:45 PM CT
    Pharmacotherapy for Anxiety Disorders: What is Available Currently and What is on the Horizon?
  • 11:30 AM – 12:45 PM CT
    Psychopharmacological Treatments for Anorexia Nervosa and Bulimia Nervosa and Future Areas of Research
  • 11:30 AM – 12:45 PM CT
    You’ve Asked Your Patient If They Are Thinking of Suicide and They Said ‘Yes’: What’s Next?
  • 1:00 PM – 2:15 PM CT
    Agitation Associated with Alzheimer’s Dementia (AAD): Clinical Presentation & Pathophysiology, Current Treatment & Unmet Need
  • 1:00 PM – 2:15 PM CT
    Beyond the Monoamine Hypothesis: A Glutamatergic Approach to Treating Major Depressive Disorder
  • 1:00 PM – 2:15 PM CT
    Coordination of Care Between Referring Psychiatrist and Treatment Center Provider
  • 1:00 PM – 2:15 PM CT
    IGALMI™ (dexmedetomidine) sublingual film • 120mcg, 180mcg • Now Approved
  • 1:00 PM – 2:15 PM CT
    TAAR1: Science Behind a Potential New TAARget for Schizophrenia
  • 1:00 PM – 2:15 PM CT
    Tardive Dyskinesia: Overcoming the Challenges of Differential Diagnosis & Treatment in the Era of Telepsychiatry
  • 2:30 PM – 3:45 PM CT
    Good Grief!: Prolonged Grief Disorder in the Context of COVID and Beyond
  • 2:30 PM – 3:45 PM CT
    Improving Shared Decision Making by Understanding Peer-Defined Treatment Outcomes
  • 2:30 PM – 3:45 PM CT
    Patient-Centered Management of Adult ADHD: Optimizing Long-Acting Stimulant Treatment
  • 2:30 PM – 3:45 PM CT
    When all else fails: New Developments in Neuromodulation for Resistant Depression
  • 4:00 PM – 5:15 PM CT
    Extensive Polypharmacy in Mood Disorders: Clever Combinations versus Clumsy Concoctions
  • 4:00 PM – 5:15 PM CT
    Impact of Trauma Across the Female Lifespan
  • 4:00 PM – 5:15 PM CT
    Long-Acting Injectable Antipsychotics: Newer Strategies for the Optimal Management of Bipolar I Disorder
  • 4:00 PM – 5:15 PM CT
    Using Antipsychotic Plasma Levels to Improve Measurement Based Care
  • 5:30 PM – 6:45 PM CT
    Managing Cognitive Complaints in Bipolar Disorder
  • 5:30 PM – 6:45 PM CT
    Nuances of Depression in High Functioning Women
  • 5:30 PM – 6:45 PM CT
    Patient Perspectives with Novel Dual Orexin Receptor Antagonists Use: Effective Treatment of Insomnia for Improved Outcomes in the Mental Health Community
  • 5:30 PM – 6:45 PM CT
    Resolving Ethical Dilemmas: How to Conduct an Ethical Analysis from Three Theoretical Perspectives
  • 7:00 PM – 8:45 PM CT
    Opening Night Reception In The Exhibit Hall
  • 7:30 PM – 8:30 PM CT
    Broadening Horizons: Artificial Intelligence and the Future of Digital Health in Psychiatry
  • Sunday, September 18, 2022
  • 7:30 AM – 8:45 AM CT
    Breaking the Cycle of Social Disparities, Stigma, and Isolation in People with Neuropsychiatric Disorders
  • 7:30 AM – 8:45 AM CT
    Clinical Evidence Supporting the Use of a Once-Daily Atypical Antipsychotic for Bipolar Depression: Bipolar I or II
  • 7:30 AM – 8:45 AM CT
    Insomnia Management: Real Patient Stories and Clinical Considerations
  • 9:00 AM – 10:15 AM CT
    Emerging Targets in the Management of Schizophrenia: The Potential of TAAR1 Agonists
  • 9:00 AM – 10:15 AM CT
    Patient Perspectives in Bipolar II Disorder
  • 9:00 AM – 10:15 AM CT
    Psychedelics as Medicine: A History of Where We’ve Been and a Map of Where We’re Going
  • 9:00 AM – 10:15 AM CT
    Solving Clinical Challenges in ADHD
  • 9:00 AM – 10:15 AM CT
    State of Substance Use
  • 10:30 AM – 11:45 AM CT
    ADHD in Women: Sex Differences and the Impact of Reproduction
  • 10:30 AM – 11:45 AM CT
    Aging Brain, Aging Mind: Understanding, Assessing and Leveraging Normal and Pathologic Changes
  • 10:30 AM – 11:45 AM CT
    Evolving Management Strategies in Major Depressive Disorder: Smarter Choices after Unsuccessful First-line Treatment
  • 10:30 AM – 11:45 AM CT
    Solving Clinical Challenges: General Anxiety Disorder
  • 10:30 AM – 11:45 AM CT
    We’re All Really Tired: Looking at Gratitude as an Antidote to Pandemic Burnout
  • 11:45 AM – 3:15 PM CT
    Exhibit Hall
  • 12:00 PM – 1:15 PM CT
    A Case of Parkinson's Disease Psychosis: Managing Hallucinations and Delusions Associated With Parkinson's Disease Psychosis
  • 12:00 PM – 1:15 PM CT
    Are you talking with your adult patients living with bipolar I disorder about maintenance treatment with a long-acting injectable (LAI)?
  • 12:00 PM – 1:15 PM CT
    Patient and clinician perspectives: Considerations when seeking treatment for depression and tools for success
  • 12:00 PM – 1:15 PM CT
    Utilizing the AIMS in Assessing for Tardive Dyskinesia
  • 1:30 PM – 3:00 PM CT
    Poster Presentations in Exhibit Hall
  • 1:45 PM – 3:15 PM CT
    AIMS Workshop
  • 2:00 PM – 3:00 PM CT
    Innovation in ADHD Symptom Coverage
  • 3:30 PM – 4:45 PM CT
    COVID19 and Moral Injury for Frontline Health Care Providers: A Mental Health Pandemic and Economic Consequences
  • 3:30 PM – 4:45 PM CT
    Depression and the Psychedelic Renaissance: Focus on Psilocybin
  • 3:30 PM – 4:45 PM CT
    This or That? Understanding the Mechanisms of Action and Clinical Applications of Novel and Emerging Therapies for Bipolar Disorder
  • 3:30 PM – 4:45 PM CT
    Working with Suicidal Clients From The LGBTQIA+ Community: Recommendations For Treatment
  • 5:00 PM – 6:15 PM CT
    Current Perspectives in Anxiety in Youth: Focus on Inflammatory Neuropsychiatric Etiologies
  • 5:00 PM – 6:15 PM CT
    Drug-Drug Interactions in Mood Disorders
  • 5:00 PM – 6:15 PM CT
    When Time is of the Essence: Postpartum Depression Treatment With GABAergic Therapies
  • 6:30 PM – 7:30 PM CT
    A Unified Vision for Transforming Mental Health and Substance Use Care
  • 8:00 PM – 11:00 PM CT
    Psych Congress Networking Event on the Riverboat City of New Orleans
  • Monday, September 19, 2022
  • 7:30 AM – 8:45 AM CT
    Paradigm Shift: A New Appreciation for Methylphenidate in Adults with ADHD
  • 7:30 AM – 8:45 AM CT
    Telehealth as Part of the Treatment Plan for Adults with Schizophrenia on Long-acting Injectables
  • 9:00 AM – 10:15 AM CT
    Breaking Down the Barriers to Utilizing Long-Acting Injectable Antipsychotics for Schizophrenia Management
  • 9:00 AM – 10:15 AM CT
    Clinical Approach To Diagnosing And Treating Complex ADHD: Focus Of The Triple Co-Morbidly Of ADHD, Anxiety, And Mood Disorders
  • 9:00 AM – 10:15 AM CT
    How to Evaluate a Stalker
  • 9:00 AM – 10:15 AM CT
    The Role of Psychiatrists in Contraception
  • 10:30 AM – 11:45 AM CT
    Clinical Considerations for Patients with Excessive Daytime Sleepiness due to Obstructive Sleep Apnea: Novel Strategies for Improved Management
  • 10:30 AM – 11:45 AM CT
    Psychedelic-assisted Psychotherapy: How is it Different from What We Already Do?
  • 10:30 AM – 11:45 AM CT
    Somatic and Pharmacological Treatments: Reducing Near-Term Suicide Risk
  • 10:30 AM – 11:45 AM CT
    State of Schizophrenia
  • 11:45 AM – 3:15 PM CT
    Exhibit Hall
  • 12:00 PM – 1:15 PM CT
    Health Disparities: How Prescription Digital Therapeutics are closing gaps in care
  • 12:00 PM – 1:15 PM CT
    How to Introduce a Long-acting Injectable With a Longer Dosing Interval for Adult Patients With Schizophrenia Into Your Practice
  • 12:00 PM – 1:15 PM CT
    Making a Difference for Patients With Tardive Dyskinesia (TD) Proactively Recognizing and Treating an Overlooked Disorder
  • 12:00 PM – 1:15 PM CT
    The Efficacy and Safety Profile of an Adjunctive Therapy for Adult Patients with Major Depressive Disorder (MDD)
  • 1:30 PM – 3:00 PM CT
    Poster Presentations in Exhibit Hall
  • 1:45 PM – 3:15 PM CT
    Long Acting Injectable (LAI) and Motivational Interviewing Workshop
  • 2:00 PM – 3:00 PM CT
    S.C.O.P.E.™ : Schizophrenia Clinical Outcome Scenarios and Patient-Provider Engagement - An Interactive Digital Platform to Educate on Schizophrenia Care
  • 3:30 PM – 4:45 PM CT
    Novel CGRP Monoclonal Antibodies and CGRP Receptor Antagonists: A Recipe for Success in Migraine Prevention and Treatment
  • 3:30 PM – 4:45 PM CT
    Solving Clinical Challenges: Treatment Resistant Depression
  • 3:30 PM – 4:45 PM CT
    The Future of Psychedelic Therapy: Training a New Generation of Clinicians
  • 3:30 PM – 4:45 PM CT
    Treating Agitation: Can We Avoid Injections? Should We?
  • 5:00 PM – 6:15 PM CT
    Neuroplasticity and Its Role in MDD: New Solutions with Digital Therapeutics
  • 5:00 PM – 6:15 PM CT
    Not Getting Better!- Diagnostic Conundrums and Treatment Considerations in Mood Disorders
  • 5:00 PM – 6:15 PM CT
    Practice-friendly evaluation and treatment of pediatric mood disorders
  • 5:00 PM – 6:15 PM CT
    The Many Faces of Ketamine: Merging Biological Psychiatry and Psychedelic Medicine
  • 6:30 PM – 7:45 PM CT
    Agitation in Alzheimer’s Dementia: Progress in an Age-Old Problem
  • 6:30 PM – 7:45 PM CT
    Incorporating the Peer Perspective in Research
  • 6:30 PM – 7:45 PM CT
    Management of OCD and Co-occurring Substance Addiction.
  • 6:30 PM – 7:45 PM CT
    Symptom Management Or Symptom Elimination? What Should Be Goal Of Treatment Of Depression In Real World Clinical Practice
  • Tuesday, September 20, 2022
  • 7:30 AM – 8:45 AM CT
    Advances in the Treatment of Insomnia
  • 7:30 AM – 8:45 AM CT
    Managing Adults With Schizophrenia: Why Consider a LAI Risperidone?
  • 9:00 AM – 10:15 AM CT
    A Framework for Evaluation and Novel Approaches to Mobile App Use for Mental Health
  • 9:00 AM – 10:15 AM CT
    Good, Better, Best: The Role of L-Methylfolate in Today’s Psychiatric/Clinical Practice
  • 9:00 AM – 10:15 AM CT
    Leveraging Recent Advances in Resilience Neurobiology to Advance the Care of Trauma Patients
  • 10:30 AM – 11:45 AM CT
    Identifying Idiopathic Hypersomnia and Narcolepsy: Novel Therapies to Provide Solutions for Difficult-to-Treat Psychiatric Patients
  • 10:30 AM – 11:45 AM CT
    Pediatric Bipolar Disorder: Essential Treatment Strategies for Optimizing Clinical Outcomes
  • 10:30 AM – 11:45 AM CT
    Understanding the Transition From Suicidal Thought to Action: The Suicide Crisis Syndrome
  • 12:00 PM – 1:15 PM CT
    Rethink Treatment for Adults With Schizophrenia or Bipolar I Disorder
  • 1:30 PM – 2:45 PM CT
    "Benzos are the Only Thing that Works” and Other Tales of Woe: Trauma Informed Difficult Conversations
  • 1:30 PM – 2:45 PM CT
    In The Trenches With Difficult To Treat Patients With Borderline Personality Disorder: Principles To Survive By
  • 1:30 PM – 2:45 PM CT
    Keeping the Patient in Mind: Novel Stimulant Treatment Approaches in Adult Patients with ADHD
  • 3:00 PM – 4:15 PM CT
    "Humor -It is a Laughing Matter: Examining the Neurobiology And Clinical Applications of Humor In Clinical Practice"
  • 4:15 PM – 4:30 PM CT
    Psych Congress 2022: Final Thoughts and Panel Discussion